Innovative Therapies for Pancreatic-Related Cancers
An excerpt from Surgical Solutions Newsletter
Pancreatic cancer patients come to Thomas Jefferson University Hospital because of the reputation, skill, and track records
of its surgical staff, who perform a high volume of surgeries. However, this patient-centric approach to care is supported
by an impressive research capability that also has significant impact on both the prevention and recovery of pancreatic-related
diseases.
Two world-class Jefferson researchers, Hwyda Arafat, MD, PhD, and Jonathan Brody, PhD, are making tremendous inroads toward
understanding the science and genesis of pancreatic-related cancers. Their goal is to manage or halt the progress of disease
through innovative and diverse therapies.
Doctors Arafat and Brody are at the forefront of research in the field today. Dr. Arafat was one of the Jefferson physicians
to represent Jefferson at the distinguished 2006 Southern Surgical Association Meeting in Florida last November, where she
presented some of her recent findings. It is their goal to leverage this work in the lab to ensure that patients survive pancreatic
cancer in increasing numbers and go on to live long and healthy lives. Read Full Article
